162 related articles for article (PubMed ID: 15347716)
1. Comparison of different quantitative approaches to 18F-fluoride PET scans.
Brenner W; Vernon C; Muzi M; Mankoff DA; Link JM; Conrad EU; Eary JF
J Nucl Med; 2004 Sep; 45(9):1493-500. PubMed ID: 15347716
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the metabolic activity of bone grafts with (18)F-fluoride PET.
Brenner W; Vernon C; Conrad EU; Eary JF
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1291-8. PubMed ID: 15197502
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.
Hawkins RA; Choi Y; Huang SC; Hoh CK; Dahlbom M; Schiepers C; Satyamurthy N; Barrio JR; Phelps ME
J Nucl Med; 1992 May; 33(5):633-42. PubMed ID: 1569473
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
5. (18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone.
Installé J; Nzeusseu A; Bol A; Depresseux G; Devogelaer JP; Lonneux M
J Nucl Med; 2005 Oct; 46(10):1650-8. PubMed ID: 16204715
[TBL] [Abstract][Full Text] [Related]
6. Quantification of 18F-Fluoride Kinetics: Evaluation of Simplified Methods.
Raijmakers P; Temmerman OP; Saridin CP; Heyligers IC; Becking AG; van Lingen A; Lammertsma AA
J Nucl Med; 2014 Jul; 55(7):1122-7. PubMed ID: 24868107
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a short dynamic 18F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics.
Peters MJ; Wierts R; Jutten EM; Halders SG; Willems PC; Brans B
Ann Nucl Med; 2015 Nov; 29(9):799-809. PubMed ID: 26243500
[TBL] [Abstract][Full Text] [Related]
8. Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Sundaram SK; Freedman NM; Carrasquillo JA; Carson JM; Whatley M; Libutti SK; Sellers D; Bacharach SL
J Nucl Med; 2004 Aug; 45(8):1328-33. PubMed ID: 15299057
[TBL] [Abstract][Full Text] [Related]
9. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans.
Freedman NM; Sundaram SK; Kurdziel K; Carrasquillo JA; Whatley M; Carson JM; Sellers D; Libutti SK; Yang JC; Bacharach SL
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):46-53. PubMed ID: 12483409
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I
J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
Wu H; Dimitrakopoulou-Strauss A; Heichel TO; Lehner B; Bernd L; Ewerbeck V; Burger C; Strauss LG
Eur J Nucl Med; 2001 Jun; 28(6):704-10. PubMed ID: 11440030
[TBL] [Abstract][Full Text] [Related]
12. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
Krak NC; van der Hoeven JJ; Hoekstra OS; Twisk JW; van der Wall E; Lammertsma AA
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):674-81. PubMed ID: 12640556
[TBL] [Abstract][Full Text] [Related]
13. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Beaulieu S; Kinahan P; Tseng J; Dunnwald LK; Schubert EK; Pham P; Lewellen B; Mankoff DA
J Nucl Med; 2003 Jul; 44(7):1044-50. PubMed ID: 12843218
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F]fluoride ion and dynamic positron emission tomography.
Berding G; Burchert W; van den Hoff J; Pytlik C; Neukam FW; Meyer GJ; Gratz KF; Hundeshagen H
Eur J Nucl Med; 1995 Oct; 22(10):1133-40. PubMed ID: 8542897
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
16. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?
Regier M; Derlin T; Schwarz D; Laqmani A; Henes FO; Groth M; Buhk JH; Kooijman H; Adam G
Eur J Radiol; 2012 Oct; 81(10):2913-8. PubMed ID: 22197090
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
19. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
20. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
